AT411323T - Cgrp receptor antagonists - Google Patents

Cgrp receptor antagonists

Info

Publication number
AT411323T
AT411323T AT05804366T AT05804366T AT411323T AT 411323 T AT411323 T AT 411323T AT 05804366 T AT05804366 T AT 05804366T AT 05804366 T AT05804366 T AT 05804366T AT 411323 T AT411323 T AT 411323T
Authority
AT
Austria
Prior art keywords
receptor antagonists
cgrp receptor
cgrp
antagonists
Prior art date
Application number
AT05804366T
Other languages
German (de)
Inventor
Christopher Burgey
Daniel Paone
Anthony Shaw
Diem Nguyen
Zhengwu Deng
Theresa WILLIAMS
Joseph VACCA
Harold Selnick
Craig Potteiger
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US61845104P priority Critical
Priority to US68383705P priority
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of AT411323T publication Critical patent/AT411323T/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
AT05804366T 2004-10-13 2005-10-12 Cgrp receptor antagonists AT411323T (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US61845104P true 2004-10-13 2004-10-13
US68383705P true 2005-05-24 2005-05-24

Publications (1)

Publication Number Publication Date
AT411323T true AT411323T (en) 2008-10-15

Family

ID=35705270

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05804366T AT411323T (en) 2004-10-13 2005-10-12 Cgrp receptor antagonists

Country Status (14)

Country Link
US (1) US8039460B2 (en)
EP (1) EP1802637B1 (en)
JP (1) JP4913061B2 (en)
KR (1) KR20070062997A (en)
AT (1) AT411323T (en)
AU (1) AU2005295729B2 (en)
BR (1) BRPI0517418A (en)
CA (1) CA2583536A1 (en)
DE (1) DE602005010463D1 (en)
IL (1) IL182317D0 (en)
MX (1) MX2007004393A (en)
NO (1) NO20072435L (en)
RU (1) RU2007117741A (en)
WO (1) WO2006044504A1 (en)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2582593A1 (en) * 2004-10-07 2006-04-20 Merck & Co., Inc. Cgrp receptor antagonists
US8168592B2 (en) 2005-10-21 2012-05-01 Amgen Inc. CGRP peptide antagonists and conjugates
AT517903T (en) 2006-05-02 2011-08-15 Squibb Bristol Myers Co antagonist compounds with reduced conformation as CGRP receptor.
US7470680B2 (en) 2006-05-03 2008-12-30 Bristol-Myers Squibb Company Constrained compounds as CGRP-receptor antagonists
AU2007284994B2 (en) 2006-05-09 2010-04-22 Merck Sharp & Dohme Corp. Substituted spirocyclic CGRP receptor antagonists
BRPI0714886A2 (en) 2006-07-10 2013-03-26 Paion Uk Ltd benzodiazepine salts and their rapid ACCO forms polimàrficas
GB0712392D0 (en) * 2007-06-26 2007-08-01 Glaxo Group Ltd Novel compounds
GB0725103D0 (en) * 2007-12-21 2008-01-30 Glaxo Group Ltd Novel compounds
US8796260B2 (en) 2008-02-19 2014-08-05 Merck Sharp & Dohme Corp. Imidazobenzazepine CGRP receptor antagonists
US8044043B2 (en) * 2008-04-11 2011-10-25 Bristol-Myers Squibb Company CGRP receptor antagonists
US8715715B2 (en) 2008-11-03 2014-05-06 Nal Pharmaceuticals Ltd. Dosage form for insertion into the mouth
WO2010070022A1 (en) * 2008-12-19 2010-06-24 Boehringer Ingelheim International Gmbh Novel compounds
EP2485589A4 (en) 2009-09-04 2013-02-06 Biogen Idec Inc Heteroaryl btk inhibitors
EP2305647A1 (en) 2009-09-18 2011-04-06 PAION UK Limited Process for preparing 3-[(4S)-8-bromo-1-methyl-6-(2-pyridinyl)-4 H-imidazo[1,2-a][1,4]benzodiazepine-4-yl] propionic acid methyl ester or the benzene sulfonate salt thereof, and compounds useful in that process
US8314117B2 (en) * 2009-10-14 2012-11-20 Bristol-Myers Squibb Company CGRP receptor antagonists
WO2012058645A1 (en) * 2010-10-29 2012-05-03 Biogen Idec Ma Inc. Heterocyclic tyrosine kinase inhibitors
EP2450039A1 (en) 2010-11-08 2012-05-09 PAION UK Ltd. Dosing regimen for sedation with CNS 7056 (Remimazolam)
US8895572B2 (en) 2010-12-22 2014-11-25 Merck Sharp & Dohme Corp. Fused heterocyclic indane carboxamide CGRP receptor antagonists
WO2013066360A1 (en) * 2010-12-22 2013-05-10 Merck Sharp & Dohme Corp. Fused heterocyclic azaindane carboxamide cgrp receptor antagonists
US9708276B2 (en) 2011-10-12 2017-07-18 University of Pittsburgh—of the Commonwealth System of Higher Education Small molecules targeting androgen receptor nuclear localization and/or level in prostate cancer
SG11201404834XA (en) 2012-02-27 2014-09-26 Squibb Bristol Myers Co N- (5s, 6s, 9r) - 5 -amino- 6 - (2, 3 - difluorophenyl) -6, 7, 8, 9 - tetrahydro - 5h - cyclohepta [b] pyridin-9 -yl- 4 - (2 - oxo-2, 3 - dihydro - 1h- imidazo [4, 5 -b] pyridin - 1 - yl) piperidine - 1 - carboxylate, hemisulfate salt
AR094963A1 (en) 2013-03-04 2015-09-09 Ono Pharmaceutical Co Excellent oxidation reaction conversion rate
GB201417707D0 (en) 2014-10-07 2014-11-19 Viral Ltd Pharmaceutical compounds
GB201519196D0 (en) 2015-10-30 2015-12-16 Heptares Therapeutics Ltd CGRP Receptor Antagonists
GB201519195D0 (en) 2015-10-30 2015-12-16 Heptares Therapeutics Ltd CGRP Receptor Antagonists
GB201519194D0 (en) 2015-10-30 2015-12-16 Heptares Therapeutics Ltd CGRP receptor antagonists
CA3012832A1 (en) 2016-02-05 2017-08-10 Denali Therapeutics Inc. Compounds, compositions and methods
EP3366286A1 (en) 2017-02-22 2018-08-29 Johannes Keller Compounds for treating sepsis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000018764A1 (en) 1998-09-30 2000-04-06 Merck Sharp & Dohme Limited Benzimidazolinyl piperidines as cgrp ligands
KR20120004541A (en) * 2002-06-05 2012-01-12 브리스톨-마이어스 스큅 컴퍼니 Calcitonin gene related peptide receptor antagonists

Also Published As

Publication number Publication date
IL182317D0 (en) 2007-07-24
US20080113966A1 (en) 2008-05-15
RU2007117741A (en) 2008-11-20
NO20072435L (en) 2007-07-12
EP1802637A1 (en) 2007-07-04
US8039460B2 (en) 2011-10-18
WO2006044504A1 (en) 2006-04-27
EP1802637B1 (en) 2008-10-15
KR20070062997A (en) 2007-06-18
CA2583536A1 (en) 2006-04-27
AU2005295729B2 (en) 2011-07-14
AU2005295729A1 (en) 2006-04-27
JP2008515991A (en) 2008-05-15
BRPI0517418A (en) 2008-10-07
DE602005010463D1 (en) 2008-11-27
MX2007004393A (en) 2007-04-25
JP4913061B2 (en) 2012-04-11
WO2006044504A8 (en) 2006-06-08

Similar Documents

Publication Publication Date Title
AT539708T (en) Wirbelfazettengelenkprothese
AT381540T (en) Oximesther-photoinitiators
CR10859A (en) Orexin receptor antagonists substituted Diazepam
AT457708T (en) Stentreduziersystem
AT447853T (en) Enyzmgranulat
AT455498T (en) Zenteseinstrument
AT395915T (en) antagonists diaryl ethers as opioid receptor
AT371694T (en) Mq-t propylsiloxanharze
AT538176T (en) Polymilchsäureharzzusammensetzung
AT444087T (en) High-balloon-catheter / component
AT546837T (en) Vertical fin-fet-mos devices
AT526869T (en) Hydratationsmonitor
AT515548T (en) iodkohlenstoffzusammensetzungen stabilized
AT442493T (en) dispenser
AT486610T (en) Anti-glypican-3 antibody
AT511206T (en) Ladungsträgerteilchenstrahlsystem
AT378330T (en) antagonist tricyclic thrombin receptor
DK1677795T3 (en) Muscarinic acetylcholine receptor antagonists
DE602005020968D1 (en) n for
AT475125T (en) metering
DE602006013493D1 (en) Oxadiazolylpyrazolopyrimidine as mGluR2 antagonists
DE602005015450D1 (en) elevator arrangement
DE502004012350D1 (en) glenoid
DK1773885T3 (en) Humanized anti-c-met antagonists
AT537141T (en) Bicycloesterderivat

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties